Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mardi 5 novembre 2019
Doi : 10.1016/j.jaad.2019.08.049
accepted : 14 August 2019
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients
 

Alan Menter, MD a : (Co-Chair), Kelly M. Cordoro, MD b, Dawn M.R. Davis, MD c, Daniela Kroshinsky, MD, MPH d, Amy S. Paller, MD e, April W. Armstrong, MD, MPH f, Cody Connor, MD g, Boni E. Elewski, MD g, Joel M. Gelfand, MD, MSCE h, Kenneth B. Gordon, MD i, Alice B. Gottlieb, MD, PhD j, Daniel H. Kaplan, MD, PhD k, Arthur Kavanaugh, MD l, Matthew Kiselica, BA/BS m, Dario Kivelevitch, MD a, Neil J. Korman, MD, PhD n, Mark Lebwohl, MD o, Craig L. Leonardi, MD p, Jason Lichten, MD m, Henry W. Lim, MD q, Nehal N. Mehta, MD, MSCE r, Sylvia L. Parra, MD s, Arun L. Pathy, MD t, Elizabeth A. Farley Prater, MD u, Reena N. Rupani, MD o, Michael Siegel, PhD v, Benjamin Stoff, MD, MA w, Bruce E. Strober, MD, PhD x, y, Emily B. Wong, MD z, Jashin J. Wu, MD aa, Vidhya Hariharan, PhD bb, , Craig A. Elmets, MD g : (Co-Chair)
a Baylor University Medical Center, Dallas, Texas 
b University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, California 
c Mayo Clinic, Rochester, Minnesota 
d Massachusetts General Hospital, Boston, Massachusetts 
e Northwestern University Feinberg School of Medicine, Chicago, Illinois 
f University of Southern California, Los Angeles, California 
g University of Alabama, Birmingham, Alabama 
h University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 
i Medical College of Wisconsin, Milwaukee, Wisconsin 
j Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York 
k University of Pittsburgh, Pittsburgh, Pennsylvania 
l University of San Diego, San Diego, California 
m National Psoriasis Foundation 
n University Hospitals Cleveland Medical Center, Cleveland, Ohio 
o Icahn School of Medicine at Mount Sinai, New York, New York 
p Central Dermatology, St Louis, Missouri 
q Department of Dermatology, Henry Ford Medical Center, Detroit, Michigan 
r National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 
s Dermatology and Skin Surgery, Sumter, South Carolina 
t Colorado Permanente Medical Group, Centennial, Colorado 
u University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 
v Pediatric Dermatology Research Alliance, Indianapolis, Indiana 
w Emory University School of Medicine, Atlanta, Georgia 
x Central Connecticut Dermatology, Cromwell, Connecticut 
y Yale University, New Haven, Connecticut 
z San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas 
aa Dermatology Research and Education Foundation, Irvine, California 
bb American Academy of Dermatology, Rosemont, Illinois 

Correspondence to: Vidhya Hariharan, PhD, American Academy of Dermatology, 9500 W Bryn Mawr Ave, Rosemont, IL 60018.American Academy of Dermatology9500 W Bryn Mawr AveRosemontIL60018
Abstract

Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.

The full text of this article is available in PDF format.

Key words : clinical guidelines for psoriasis, comorbidities, dermatology, guidelines, pediatric, pediatric psoriasis, psoriasis, psoriasis guidelines, skin disease

Abbreviations used : AAD, AAP, aHR, AOR, BMI, BSA, CDLQI, CI, FDA, GI, HPA, ICD, IL, LDL, NAFLD, NB, OR, PASI, PASI 75, PPD, PSA, PUVA, QOL, TCI, TNF, UV, UVA, UVB



 Funding sources: None.
 Conflicts of interest: Listed in text.
 Reprints not available from the authors.



© 2019  American Academy of Dermatology, Inc. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline